Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

New research explores the wide world of the positives, and potential drawbacks, of new obesity medications. And each brings a new consideration for physicians.

Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're about to lose access.

Amy Schumer lost 30 pounds using Ozempic, but experienced negative side effects. She was "bedridden" and didn't have energy. Amy has a gene that makes her "prone to nausea," which she believes is ...

Over a decade ago, a smattering of studies suggested that early cousins of drugs like Ozempic and Mounjaro could prevent, or even reverse, signs of Alzheimer’s disease in mice. Now, as the next ...

The Montreal Canadiens and the Ottawa Senators will face off in Quebec on September 30. The two teams will compete for victory in a preseason game. That being said, tickets for the match went on sale ...

Ozempic, the diabetes medication popularly used as an “off-label” weight-loss drug, has helped thousands shed excess pounds. Now, a new study finds that Ozempic, along with similar drugs such ...